FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37367211000001106: Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jul 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
300941000001117 Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
300951000001119 Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) Is a Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials true Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) Has dispensed dose form Powder and solvent for solution for infusion true Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) Has specific active ingredient Epoprostenol sodium true Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Epoprostenol true Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) 1 vial Has AMP True Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start